GE HealthCare Adds AI Features to Vscan Air Ultrasound
Chicago, Illinois, United States, November 3, 2026 GE HealthCare has announced two new artificial intelligence (AI)-assisted capabilities for its...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Chicago, Illinois, United States, November 3, 2026 GE HealthCare has announced two new artificial intelligence (AI)-assisted capabilities for its...
Amsterdam, the Netherlands, September 3, 2026 Royal Philips has introduced the eV14-2v transvaginal transducer, a new single-transducer solution designed...
